Section 64 National Health Act

Section 64 National Health Act 2014 is about Interpretation. It is under Part VII (Regulations and Miscellaneous Provisions) of the Act.

In this Act—
“appropriate authority” means any other authority apart from the Minister, Commissioner, Executive Secretary, Chairmen of Boards or Agencies ;
“basic minimum package” means the set of health services as may be prescribed from time to time by the Minister after consultation with the National Council on Health ;

“blood product” means any product derived or produced from blood, including circulating progenitor cells, bone marrow progenitor cells and umbilical cord progenitor cells ;
“certificate” means the certificate of standards specified under section 13 of this Act ;
“Commissioner” means the Commissioner of a State responsible for health ;
“communicable disease” means a disease resulting from an infection due to pathogenic agents or toxins generated by the infection, following the direct or indirect transmission of the agents from the source to the host ;
*Constitution”’ means the Constitution of the Federal Republic of Nigeria, 1999 ;

“death” means brain death ;
“embryo” means a human offspring in the first eight weeks from conception ;
“Federal Ministry” means the Federal Ministry of Health ;
“gamete” means either of the two generative cells essential for human reproduction ;
“gonad” means a human testis or human ovary ;

“health agency’’ means any person or entity other than a health establishment—
(a) whose business involves the supply of health care personnel to users or health establishments ;
(b) who employs health care personnel for the purpose of providing health services ; or
(c) who procures health care personnel or health services for the benefit of a user, and includes a temporary employment service involving health workers or health care providers ;
“health care personnel” means health care providers and health workers ;
“health care provider” means a person providing health services under this Act or any other law ;

“health establishment” means the whole or part of a public or private institution, facility, building or place, whether for profit or not, that is operated or designed to provide inpatient or outpatient treatment, diagnostic or therapeutic interventions, nursing, rehabilitative, palliative, convalescent, preventative or other health service under section 12 of this Act ;
“health research” includes any research which contributes to knowledge
of—
(a) the biological, clinical, psychological or social processes in human beings ;
(b) improved methods for the provision of health services ;
(c) human pathology ;
(d) the causes of disease ;
(e) the effects of the environment on the human body ;

(f) the development or new application of pharmaceuticals, medicines and related substances ; and
(g) the development of new applications of health technology ;
“health research ethics committee’’ means any committee established under section 34 of this Act ;

“health services’ means health care services that are preventive,
protective, promotive, curative and rehabilitative in respect of physical mental
and social well being ;
“health technology’ means machinery or equipment that is used in the
provision of health services, but does not include medicine as defined in the
Drugs and Related Products Registration etc Act. No. 19 of 1993 ;
“health worker” means any person who is involved in the provision of
health services to a user, but does not include a health care provider ;
hospital” means a health establishment which is classified as a hospital
by the Minister under section 12 of this Act ;
“ Minister” means the Minister charged with responsibility for matters
relating to health ;
** National Council on Health” means the Council established by section
4 of this Act;

“National Health Policy” means all policies relating to issues of national health as approved by the Federal Executive Council on the advice of the National Council on Health through the Minister ;
“National Health Research Committee” means the Committee established under section 31 ;
“National Health Research Ethics Committee” means the Committee established under section 33of this Act ;

“National Health System” means the system within the Federal Republic of Nigeria, whether in the public or private sector, concerned with the financing, provision or delivery and regulation of health services ;
“non-communicable disease” means a disease or health condition that cannot be contracted from another person, an animal or directly from the environment ;

“norm” means a Statistical normative rate of provision or measurable target outcome over a specified period of time ;
“NPHCDA” means the National Primary Health Care Development Agency ;
“oocyte” means a developing human egg cell ;
“argan” means any part of the human body adapted by its structure to perform any particular vital function, including the eye and its accessories, but does not include skin and appendages, flesh, bone, bone marrow, body fluid, blood ora gamete ;
“Permanent Secretary” means the administrative head of the Federal Ministry of Health or a State Ministry of Health ;

“premises” means any building, structure or tent together with the land on which it is situated and the adjoining land used in connection with it and includes any land without any building, structure or tent and any vehicle, conveyance or ship ;

“prescribed” means prescribed by regulation made under section 59 of this Act;
“primary health care services” means such health services as may be prescribed by the Minister to be primary health care services ;

“private health establishment” means a health establishment that is not owned or controlled by an organ of state ;
“public health establishment” means a health establishment that is owned or controlled by a government body ;
“reasonable cause” means any extenuating circumstance that prevents the healthcare provider, health worker or health establishment from providing emergency medical treatment to a person ;
“rehabilitation” means a goal-orientated and time-limited process aimed at enabling impaired persons to reach an optimum mental, physical or social functional level ;
“reproductive cloning of a human being” means the manipulation of genetic material in order to achieve the cloning of a human being and includes nuclear transfer or embryo splitting for such purpose ;

“State Ministry” means any State Ministry responsible for health ;
“Statutory Health Professional Council” means a professional regulatory body established by any Act or Law ;
“Technical Committee” means the Technical Committee of the National Health Council on Health established under section 6 of this Act ;

“Tertiary Hospital” means a public or private hospital approved by the National Tertiary Hospital Committee to provide health services at a tertiary specialist level of care ;
“therapeutic cloning” means the manipulation of genetic material from adult, zygotic or embryonic cells in order to alter, for therapeutic purposes, the function of cells or tissues ;
“this Act” includes any regulation made thereunder ;
“tissue’’ means human tissue, and includes flesh, bone, a gland, an organ, skin, bone marrow or body fluid, but excludes blood or a gamete ;

“use”, in relation to tissue, includes preserve or dissect ;
“user” means the person receiving treatment in a health establishment, including receiving blood or blood products, or using a health service, and if the person receiving treatment or using a health service is—
(a) below the majority age,
“user” includes the person’s parent or guardian or another person authorised by law to act on the first mentioned person’s behalf ; or incapable of taking decisions,
“user” includes the person’s spouse or ;
(b) in the absence of such spouse, the person’s parent, grandparent, adult child, brother, sister, or another;
(c) person authorised by law to act on the first mentioned person’s behalf ; and
“zygote” means the product of the union of a male and a female gamete.